TY - JOUR
T1 - A perspective on the developmental toxicity of inhaled nanoparticles
AU - Hougaard, Karin Sørig
AU - Campagnolo, Luisa
AU - Chavatte-Palmer, Pascale
AU - Tarrade, Anne
AU - Rousseau-Ralliard, Delphine
AU - Valentino, Sarah
AU - Park, Margriet V D Z
AU - de Jong, Wim H
AU - Wolterink, Gerrit
AU - Piersma, Aldert H
AU - Ross, Bryony L
AU - Hutchison, Gary R
AU - Hansen, Jitka Stilund
AU - Vogel, Ulla
AU - Jackson, Petra
AU - Slama, Rémy
AU - Pietroiusti, Antonio
AU - Cassee, Flemming R
N1 - Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2015/8/15
Y1 - 2015/8/15
N2 - This paper aimed to clarify whether maternal inhalation of engineered nanoparticles (NP) may constitute a hazard to pregnancy and fetal development, primarily based on experimental animal studies of NP and air pollution particles. Overall, it is plausible that NP may translocate from the respiratory tract to the placenta and fetus, but also that adverse effects may occur secondarily to maternal inflammatory responses. The limited database describes several organ systems in the offspring to be potentially sensitive to maternal inhalation of particles, but large uncertainties exist about the implications for embryo-fetal development and health later in life. Clearly, the potential for hazard remains to be characterized. Considering the increased production and application of nanomaterials and related consumer products a testing strategy for NP should be established. Due to large gaps in data, significant amounts of groundwork are warranted for a testing strategy to be established on a sound scientific basis.
AB - This paper aimed to clarify whether maternal inhalation of engineered nanoparticles (NP) may constitute a hazard to pregnancy and fetal development, primarily based on experimental animal studies of NP and air pollution particles. Overall, it is plausible that NP may translocate from the respiratory tract to the placenta and fetus, but also that adverse effects may occur secondarily to maternal inflammatory responses. The limited database describes several organ systems in the offspring to be potentially sensitive to maternal inhalation of particles, but large uncertainties exist about the implications for embryo-fetal development and health later in life. Clearly, the potential for hazard remains to be characterized. Considering the increased production and application of nanomaterials and related consumer products a testing strategy for NP should be established. Due to large gaps in data, significant amounts of groundwork are warranted for a testing strategy to be established on a sound scientific basis.
KW - Nanoparticles
KW - Nanomaterial
KW - Ultrafine particles
KW - Developmental toxicity
KW - Reproductive toxicity
KW - Inhalation
KW - Instillation
KW - Pregnancy
U2 - 10.1016/j.reprotox.2015.05.015
DO - 10.1016/j.reprotox.2015.05.015
M3 - Article
C2 - 26050605
SN - 0890-6238
VL - 56
SP - 118
EP - 140
JO - Reproductive Toxicology
JF - Reproductive Toxicology
ER -